<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Value Research Online</title>
        <atom:link href="/stories/stock/41398/biocon-ltd/rss/" rel="self" type="application/rss+xml" />
        <link>https://www.valueresearchonline.com/</link>
        <description>RSS Feeds | Value Research</description>
        <language>en</language>
        <copyright>Copyright 2026 Value Research India Private Limited.</copyright>
        <image>
            <title>Value Research</title>
            <url>https://www.valueresearchonline.com/assets/images/valueresearchonline-desktop.png</url>
            <link>https://www.valueresearchonline.com/</link>
        </image>

        <item>
			<title>Big shifts</title>
			<link>https://www.valueresearchonline.com/stories/45832/big-shifts/</link>
			<pubDate>Wed, 04 Jul 2018 06:54:15 +0530</pubDate>
			<category>Data for Thought</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/45832_oppotunity__w320__h240__.jpg&quot; alt=&quot;Big shifts&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Here are some companies that have significantly grown and shrunk in size over the last 10 years</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/45832/big-shifts/</guid>
		</item>
		<item>
			<title>Mr Contrarian</title>
			<link>https://www.valueresearchonline.com/stories/35652/mr-contrarian/</link>
			<pubDate>Mon, 14 May 2018 11:38:54 +0530</pubDate>
			<category>Stockwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/35652_sankaran_naren__w320__h240__.jpg&quot; alt=&quot;Mr Contrarian&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Sankaran Naren goes against market sentiments to buy stocks that seem lukewarm and turns the fund scorching hot</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/35652/mr-contrarian/</guid>
		</item>
		<item>
			<title>Attractive Prospects</title>
			<link>https://www.valueresearchonline.com/stories/16763/attractive-prospects/</link>
			<pubDate>Fri, 08 Apr 2011 15:50:00 +0530</pubDate>
			<category>Stock Analyst Choice</category>
			<description>The recent Pfizer deal &amp; the possibility of producing a breakthrough product augur well for Biocon…></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/16763/attractive-prospects/</guid>
		</item>
		<item>
			<title>In The Pink Of Health</title>
			<link>https://www.valueresearchonline.com/stories/11343/in-the-pink-of-health/</link>
			<pubDate>Tue, 20 May 2008 14:32:00 +0530</pubDate>
			<category>Fundwire</category>
			<description>Pharma funds have staged a smart recovery after posting negative returns for the past few years></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/11343/in-the-pink-of-health/</guid>
		</item>
    </channel>
</rss>
